COMPANY PROFILE

Apollo Neuro

Explore full profile

Wellness product, the first clinically validated wearable that actively helps body recover from stress

Pittsburgh, United StatesFounded 2016Health Tech & Medtech

Valuation $100–250M Last recorded · 2023

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Apollo Neuro

Apollo Neuroscience operates in the health and wellness market, offering innovative wearable technology designed to improve stress resilience, sleep quality, and focus through touch therapy. The company's primary product, the Apollo wearable, uses scientifically-backed vibrations to help users relax, sleep better, and enhance overall well-being. Apollo Neuroscience targets health-conscious consumers seeking non-invasive solutions to manage stress and improve mental and physical health. The business model revolves around direct-to-consumer sales through its website, with additional revenue generated from accessories and replacement parts. By leveraging cutting-edge science and user-friendly design, Apollo Neuroscience aims to provide an effective alternative to traditional stress relief and sleep aids.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Pittsburgh, United States
Employees: 17
Open positions: None listed
Dealroom signal: 75.5/100
Industry: Health, Wellness Beauty
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Immersive Technologies, Spinout, Sustainable Development Goals, Haptics, Hard Tech, DT and LS, science-based
Technology: Hardware, Deep Tech
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

10 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VC✓Equity / VC	Sep 2023	$9.8M	$100M	Portfolia Funds	↗
CONVERTIBLEEquity / VC	May 2023	$0	—	Innovation Works	—

Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Apollo Neuro website traffic

Latest recorded traffic for Apollo Neuro is 140K monthly website visits, down 6.7% over the last three months. Apollo Neuro's team declined 10.5% over the past year.

Latest monthly visits140K 3-month web change-6.7% 1-year team growth-10.5%

Monthly website visitsDec 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ACAcuSurgicalCreating the new standard of care in retinal surgery	Montpellier, France	Operational	48	$6.3M	$25M
MEMedicsenNeedle-free drug delivery platform based on sonophoresis (ultrasounds) to replace needles and cannulas in the transdermal delivery of large molecules	Madrid, Spain	Operational
MIMindMazeDigital neuro-therapeutics for brain health and recovery	Lausanne, Switzerland	Acquired
DODotCertified B-corporation and a social venture that seeks to remove all barriers from everyday life for the blind, low-vision, and mobility handicapped	Seoul, South Korea	Operational
FNFlow NeuroscienceDevelops a new kind of depression treatment which combines an easy-to-use brain stimulation headset with a personalized mobile app	Malmö kommun, Sweden	Operational
ABATRO Medical B.V.ATRO Medical's Artimis Meniscus Prosthesis reduces pain and restores mobility for patients suffering from chronic pain after loss of their meniscus	Nijmegen, Netherlands	Operational
MOMorecognitionEnhanced rehabilitation for greater autonomy	Turin, Italy	Operational
SOSomnoxSpecialized in soft-robotic innovation to improve the quality of night of sleep	Rotterdam, Netherlands	Operational